Impact of Cold Ischemia Time, Operative Time, and Time of Day Transplant Performed on Deceased Donor Renal Transplant Graft Survival with Alemtuzumab Induction

Trial Profile

Impact of Cold Ischemia Time, Operative Time, and Time of Day Transplant Performed on Deceased Donor Renal Transplant Graft Survival with Alemtuzumab Induction

Completed
Phase of Trial: Phase II

Latest Information Update: 19 Aug 2015

At a glance

  • Drugs Alemtuzumab (Primary)
  • Indications Renal transplant rejection
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Aug 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top